BioSpace News Archive

Business

Renovacor’s Marc Semigran Transitioned to Industry to Put Patients First

The burgeoning genetic capabilities were instrumental in causing Semigran to transition into the biotech industry.

August 30, 2021
·
4 min read
·
Gail Dutton
Lysogene Announces First Patient in the United States Dosed with LYS-GM101 Investigational Gene Therapy for the Treatment of GM1 Gangliosidosis

Lysogene, a phase 3 gene therapy platform company targeting central nervous system diseases, announced dosing of the first patient in the United States with LYS-GM101 investigational gene therapy at CHOC Hospital in a global adaptative-design clinical trial for the treatment of GM1 gangliosidosis.

August 30, 2021
·
5 min read
Innate Pharma to Participate in Upcoming Investor Conferences - Aug 30, 2021

Innate Pharma SA announced that members of its senior management team are scheduled to participate in the following upcoming virtual investor conferences:

August 30, 2021
·
3 min read
Taurine Market: Rise in demand for taurine for body building and fitness is anticipated to drive the market

Taurine is a type of amino acid that is essential for building protein blocks in the body. It is irreplaceable for healthy growth of infants as well for those at risks from various diseases.

August 30, 2021
·
5 min read
Computer-Assisted Orthopedic Surgery Demand Increasing At 5.5% CAGR Spurred by Surging Burden of Musculoskeletal Conditions

Fact.MR – A Market Research and Competitive Intelligence Provider: As per a market research survey conducted by Fact.MR, the global computer-assisted orthopedic surgery market is anticipated to project a steady growth at a CAGR of 5.5% over the forecast period 2021 to 2031.

August 30, 2021
·
7 min read
XPhyto Launches First Commercial Biosensor for Oral Disease

XPhyto Therapeutics Corp. with its partner and acquisition target, 3a-diagnostics GmbH, has successfully registered their first biosensor test in oral inflammation with the German authorities.

August 30, 2021
·
6 min read
Biotech Bay

IDEAYA Biosciences to Participate in Investor Conferences in September 2021

IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in investor conferences in September 2021.

August 30, 2021
·
2 min read
Genetown

Vizgen Releases Commercial MERSCOPE Platform

Vizgen, the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, announced shipment of the first commercial MERSCOPETM Platforms, marking the successful start of their limited summer release program.

August 30, 2021
·
5 min read
Deals

Revelation Biosciences, Inc., a Life Sciences Company Developing Therapeutics and Diagnostics for Respiratory Viral Infections, Including COVID-19, to Become Publicly Traded Through a Merger with Petra Acquisition, Inc.

Revelation Biosciences, Inc. and Petra Acquisition, Inc. announced they have entered into a definitive merger agreement for a business combination that will result in Revelation becoming a publicly traded company.

August 30, 2021
·
16 min read
Biotech Beach

MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the 32nd International Symposium on ALS/MND

ediciNova, Inc. announced that an abstract regarding MediciNova’s ongoing Phase 2b/3 clinical trial of MN-166 in amyotrophic lateral sclerosis has been accepted for presentation at the 32nd International Symposium on ALS/MND to be held virtually on December 7 - 10, 2021.

August 30, 2021
·
6 min read